Heeson Lee
SEC CIK 2039219 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | EVP, Head of Incyte Intl | 38.0K | — | $289.0K | 6 | 2024-10-01 | 2026-02-02 |
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | 2026-02-02 | INCY | Incyte | Heeson Lee | EVP, Head of Incyte Intl | F - Tax | $102.67 | -111 | 38.0K | -0.3% | -$11.4K | |
| 2026-01-21 | 2026-01-16 | INCY | Incyte | Heeson Lee | EVP, Head of Incyte Intl | A - Grant | $0.00 | +8,911 | 38.2K | +30% | $0 | |
| 2025-11-05 | 2025-11-03 | INCY | Incyte | Heeson Lee | EVP, Head of Incyte Intl | S - Sale | $94.02 | -3,074 | 29.2K | -10% | -$289.0K | |
| 2025-10-03 | 2025-10-01 | INCY | Incyte | Heeson Lee | EVP, Head of Incyte Intl | F - Tax | $86.70 | -463 | 32.3K | -1% | -$40.1K | |
| 2025-02-03 | 2025-01-31 | INCY | Incyte | Heeson Lee | EVP, Head of Incyte Intl | A - Grant | $0.00 | +6,331 | 32.8K | +24% | $0 | |
| 2024-10-03 | 2024-10-01 | INCY | Incyte | Heeson Lee | EVP, Head of Incyte Intl | A - Grant | $0.00 | +26.4K | 26.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations